1,2,4-Thiadiazole derivatives as effective NMDA receptor blockers with anticholinesterase activity and antioxidant properties
- 1 July 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Russian Chemical Bulletin
- Vol. 66 (7), 1308-1313
- https://doi.org/10.1007/s11172-017-1890-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaScientific Reports, 2016
- AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS DisordersJournal of Alzheimer's Disease, 2016
- Novel GluN2B selective NMDA receptor antagonists: relative configuration of 7-methoxy-2-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-1-olsActa Crystallographica Section E: Crystallographic Communications, 2016
- Multi-target Design Strategies in the Context of Alzheimer’s Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving ForcesNeurochemical Research, 2014
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and diseaseNature Reviews Neuroscience, 2013
- Rationally Designed Multi-Targeted Agents Against Neurodegenerative DiseasesCurrent Medicinal Chemistry, 2013
- Key Binding Interactions for Memantine in the NMDA ReceptorACS Chemical Neuroscience, 2012
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive DisorderJournal of Clinical Psychopharmacology, 2012
- Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potentialBritish Journal of Pharmacology, 2009
- NMDA receptors in clinical neurology: excitatory times aheadThe Lancet Neurology, 2008